Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Gsk (GLAXF) Pension (2016 - 2025)

Historic Pension for Gsk (GLAXF) over the last 17 years, with Q3 2025 value amounting to -$2.2 billion.

  • Gsk's Pension rose 1485.83% to -$2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.2 billion, marking a year-over-year increase of 1485.83%. This contributed to the annual value of -$2.4 billion for FY2024, which is 18186.46% down from last year.
  • Latest data reveals that Gsk reported Pension of -$2.2 billion as of Q3 2025, which was up 1485.83% from -$2.3 billion recorded in Q2 2025.
  • Gsk's 5-year Pension high stood at $4.2 billion for Q4 2021, and its period low was -$4.8 billion during Q1 2021.
  • Moreover, its 5-year median value for Pension was -$2.8 billion (2024), whereas its average is -$2.0 billion.
  • As far as peak fluctuations go, Gsk's Pension skyrocketed by 9281.68% in 2022, and later plummeted by 77754.78% in 2023.
  • Over the past 5 years, Gsk's Pension (Quarter) stood at $4.2 billion in 2021, then dropped by 27.91% to $3.0 billion in 2022, then decreased by 3.99% to $2.9 billion in 2023, then crashed by 182.38% to -$2.4 billion in 2024, then increased by 6.23% to -$2.2 billion in 2025.
  • Its Pension stands at -$2.2 billion for Q3 2025, versus -$2.3 billion for Q2 2025 and -$2.4 billion for Q1 2025.